Gut bacterial tyrosine decarboxylase gene abundance associates with disease duration, medication exposure, and gastrointestinal symptoms in a longitudinal cohort of Parkinson’s disease patients

Sebastiaan P. van Kessel, Petri Auvinen, Filip Scheperjans, Sahar El Aidy
doi: https://doi.org/10.1101/2021.07.13.21259300

Article Information

doi 
https://doi.org/10.1101/2021.07.13.21259300
History 
  • July 15, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sebastiaan P. van Kessel1,
  2. Petri Auvinen2,
  3. Filip Scheperjans3,*,# and
  4. Sahar El Aidy1,*,#
  1. 1Host-Microbe Metabolic Interactions, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Groningen, the Netherlands
  2. 2Institute of Biotechnology, DNA Sequencing and Genomics Laboratory, University of Helsinki, Viikinkaari 5D, 00014 Helsinki, Finland
  3. 3Department of Neurology, Helsinki University Hospital, and Clinicum, University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland
  1. ↵#Correspondence Filip Scheperjans and Sahar El Aidy email: sahar.elaidy{at}rug.nl
Back to top
Posted July 15, 2021.
Download PDF
Data/Code
Email
Gut bacterial tyrosine decarboxylase gene abundance associates with disease duration, medication exposure, and gastrointestinal symptoms in a longitudinal cohort of Parkinson’s disease patients
Sebastiaan P. van Kessel, Petri Auvinen, Filip Scheperjans, Sahar El Aidy
medRxiv 2021.07.13.21259300; doi: https://doi.org/10.1101/2021.07.13.21259300
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area